Patents by Inventor Ivana Basarabova

Ivana Basarabova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11427652
    Abstract: A chlorinated derivative of hyaluronic acid or of a modified hyaluronic acid (chloramide) is provided. The chloramide has an amidic group (—NH—CO—). The hydrogen of the amidic group is substituted by a chlorine atom, according to the structural formula —NCl—CO—. The substitution degree of the hyaluronic acid or of the modified hyaluronic acid by chlorine is in an amount of from 50 to 100 %.
    Type: Grant
    Filed: August 17, 2019
    Date of Patent: August 30, 2022
    Assignee: CONTIPRO A.S.
    Inventors: Radovan Buffa, Ivana Basarabova, Martina Hermannova, Katerina Knotkova, Jaromir Kulhanek, Josef Chmelar, Tomá{hacek over (s)} Pitucha, Drahomira Chladkova, Helena Krejci, Hana Vagnerova, Martin Sojka, Lubos Sobotka, Vladimir Velebny
  • Patent number: 11425907
    Abstract: An antimicrobial composition is provided. The composition comprises a chloramid of hyaluronic acid or of modified hyaluronic acid. The chloramid has an amidic group (—NH—CO—). The hydrogens of the amidic group are substituted by chlorine atoms according to the structural formula —NCl—CO—. The composition further comprises an iodide. The substitution degree of the hyaluronic acid or of the modified hyaluronic acid by chlorine is in an amount of from 50% to 100%.
    Type: Grant
    Filed: August 17, 2019
    Date of Patent: August 30, 2022
    Assignee: CONTIPRO A.S.
    Inventors: Radovan Buffa, Vit Svozil, Katerina Knotkova, Veronika Stepankova, Jaromir Kulhanek, Josef Chmelar, Lucie Marholdova, Ivana Basarabova, Michaela Moravkova, Helena Krejci, Kristyna Lipenska, Jaroslav Novotny, Stanislav Pepeliaev, Lubos Sobotka, Vladimir Velebny
  • Publication number: 20210345610
    Abstract: An antimicrobial composition is provided. The composition comprises a chloramid of hyaluronic acid or of modified hyaluronic acid. The chloramid has an amidic group (—NH—CO—). The hydrogens of the amidic group are substituted by chlorine atoms according to the structural formula —NCl—CO—. The composition further comprises an iodide. The substitution degree of the hyaluronic acid or of the modified hyaluronic acid by chlorine is in an amount of from 50% to 100%.
    Type: Application
    Filed: August 17, 2019
    Publication date: November 11, 2021
    Inventors: Radovan BUFFA, Vit SVOZIL, Katerina KNOTKOVA, Veronika STEPANKOVA, Jaromir KULHANEK, Josef CHMELAR, Lucie MARHOLDOVA, Ivana BASARABOVA, Michaela MORAVKOVA, Helena KREJCI, Kristyna LIPENSKA, Jaroslav NOVOTNY, Stanislav PEPELIAEV, Lubos SOBOTKA, Vladimir VELEBNY
  • Publication number: 20210332161
    Abstract: A chlorinated derivative of hyaluronic acid or of a modified hyaluronic acid (chloramide) is provided. The chloramide has an amidic group (—NH—CO—). The hydrogen of the amidic group is substituted by a chlorine atom, according to the structural formula —NCl—CO—. The substitution degree of the hyaluronic acid or of the modified hyaluronic acid by chlorine is in an amount of from 50 to 100 %.
    Type: Application
    Filed: August 17, 2019
    Publication date: October 28, 2021
    Inventors: Radovan BUFFA, Ivana BASARABOVA, Martina HERMANNOVA, Katerina KNOTKOVA, Jaromir KULHANEK, Josef CHMELAR, Tomás PITUCHA, Drahomira CHLADKOVA, Helena KREJCI, Hana VAGNEROVA, Martin SOJKA, Lubos SOBOTKA, Vladimir VELEBNY
  • Publication number: 20200179445
    Abstract: A composition having antimicrobial activity is provided. The composition comprises a polysaccharide, a stabilizer, and a triiodide, where the triiodide decomposition to iodide and volatile iodine can be significantly suppressed by the presence of the stabilizer. Methods of preparing and using the composition and devices prepared therewith are also disclosed. As compared to liquid forms comprising triiodide, stabilized solid forms can be used for a much wider range of applications due to their shape stability and a significantly smaller volume and weight of total material.
    Type: Application
    Filed: June 1, 2018
    Publication date: June 11, 2020
    Inventors: Radovan BUFFA, Veronika STEPANKOVA, Ivana BASARABOVA, Josef CHMELAR, Katerina MAIRYCHOVA, Vojtech ZAPOTOCKY, Tomas PITUCHA, Katerina KNOTKOVA, Lubos SOBOTKA, Kristyna LIPENSKA, Vladimir VELEBNY
  • Patent number: 10618984
    Abstract: The invention relates to the preparation of new polysaccharide derivatives comprising a double bond in the positions 4 and 5 of the pyranose cycle. The method of preparation consists in the oxidation of OH group in the position 6 to an aldehyde, followed by the elimination to form a double —C?C— bond in the positions 4 and 5, and the final reduction of the aldehyde group in the position 6 into the original alcohol. The derivatives of polysaccharides prepared according to the invention show an enhanced antioxidant activity and some of them also a selective negative influence on carcinoma cell viability. (formula) where R represents —NH—CO—CH3 or —OH.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: April 14, 2020
    Assignee: Contipro a.s.
    Inventors: Radovan Buffa, Tomas Bobula, Petra Sedova, Ivana Basarabova, Pavlina Prochazkova, Hana Vagnerova, Iva Doleckova, Sona Moravcikova, Vladimir Velebny
  • Publication number: 20190169317
    Abstract: The invention relates to the preparation of new polysaccharide derivatives comprising a double bond in the positions 4 and 5 of the pyranose cycle. The method of preparation consists in the oxidation of OH group in the position 6 to an aldehyde, followed by the elimination to form a double —C?C— bond in the positions 4 and 5, and the fmal reduction of the aldehyde group in the position 6 into the original alcohol. The derivatives of polysaccharides prepared according to the invention show an enhanced antioxidant activity and some of them also a selective negative influence on carcinoma cell viability. (formula) where R represents —NH—CO—CH3 or —OH.
    Type: Application
    Filed: June 26, 2017
    Publication date: June 6, 2019
    Applicant: Contipro a.s.
    Inventors: Radovan Buffa, Tomas Bobula, Petra Sedova, Ivana Basarabova, Pavlina Prochazkova, Hana Vagnerova, Iva Doleckova, Sona Moravcikova, Vladimir Velebny
  • Patent number: 10023658
    Abstract: The invention relates to conjugates of hyaluronic acid oligomer according to the general formulae I, II III or IV, or a salt thereof, the method of preparation thereof and use thereof, where the oligomer is bonded to the respective substrate by its ending anomeric center via a bi-functional amino linker by means of an amino or imino bond. This type of conjugates allows releasing oligomers in their native form. The prepared systems exhibited an enhanced biological activity against selected lines of cancer cells.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: July 17, 2018
    Assignee: Contipro a.s.
    Inventors: Radovan Buffa, Ivana Basarabova, Kristina Nesporova, Tereza Ehlova, Ondrej Kotland, Petra Sedova, Leos Hromek, Vladimir Velebny
  • Publication number: 20170015759
    Abstract: The invention relates to conjugates of hyaluronic acid oligomer according to the general formulae I, II III or IV, or a salt thereof, the method of preparation thereof and use thereof, where the oligomer is bonded to the respective substrate by its ending anomeric center via a bi-functional amino linker by means of an amino or imino bond. This type of conjugates allows releasing oligomers in their native form. The prepared systems exhibited an enhanced biological activity against selected lines of cancer cells.
    Type: Application
    Filed: March 10, 2015
    Publication date: January 19, 2017
    Inventors: Radovan Buffa, Ivana Basarabova, Kristina Nesporova, Tereza Ehlova, Ondrej Kotland, Petra Sedova, Leos Hromek, Vladimir Velebny
  • Patent number: 9522966
    Abstract: The invention relates to the preparation and use of ?,?-unsaturated aldehyde of hyaluronan having a double bond in the positions 4 and 5 and an aldehydic group in the position 6 of the glucosamine part of the polysaccharide. The method of preparation is based on dehydration of hyaluronan having an aldehydic group in the position 6 of the glucosamine part of the polysaccharide. Two methods have been described, which are dehydration in a solution or heating in solid state in absence of solvents, bases or other additives. This derivative allows stabilization of conjugates of hyaluronan with amino compounds by means of a multiple bond from the aldehyde side, and therefore, it is possible to effectively immobilize practically any compound containing an amino group to such modified hyaluronan in physiological conditions. In case of using a diamine or compounds or polymers containing three or more amino groups, it is possible to prepare crosslinked hyaluronan derivatives.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: December 20, 2016
    Assignee: Contipro Biotech s.r.o.
    Inventors: Radovan Buffa, Petra Sedova, Vladimir Velebny, Lucie Wolfova, Ivana Basarabova, Robert Pospisil, Martina Hasova, Kristina Nesporova
  • Publication number: 20150175717
    Abstract: The invention relates to the preparation and use of ?,?-unsaturated aldehyde of hyaluronan having a double bond in the positions 4 and 5 and an aldehydic group in the position 6 of the glucosamine part of the polysaccharide. The method of preparation is based on dehydration of hyaluronan having an aldehydic group in the position 6 of the glucosamine part of the polysaccharide. Two methods have been described, which are dehydration in a solution or heating in solid state in absence of solvents, bases or other additives. This derivative allows stabilization of conjugates of hyaluronan with amino compounds by means of a multiple bond from the aldehyde side, and therefore, it is possible to effectively immobilize practically any compound containing an amino group to such modified hyaluronan in physiological conditions. In case of using a diamine or compounds or polymers containing three or more amino groups, it is possible to prepare crosslinked hyaluronan derivatives.
    Type: Application
    Filed: August 8, 2013
    Publication date: June 25, 2015
    Applicant: CONTIPRO BIOTECH S.R.O.
    Inventors: Radovan Buffa, Petra Sedova, Vladimir Velebny, Lucie Wolfova, Ivana Basarabova, Robert Pospisil, Martina Hasova, Kristina Nesporova